Paragon Care Limited (ASX:PGC)

Market Cap	231.74M -55.6%
Revenue (ttm)	3.68B +1.8%
Net Income	-16.03M
EPS	-0.01
Shares Out	1.66B
PE Ratio	n/a
Forward PE	7.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	663,780
Open	0.1400
Previous Close	0.1350
Day's Range	0.1370 - 0.1450
52-Week Range	0.1250 - 0.3250
Beta	-0.28
Analysts	Buy
Price Target	0.25 (+78.57%)
Earnings Date	Aug 26, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 550
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PGC

Analyst Summary

According to 2 analysts, the average rating for PGC stock is "Buy." The 12-month stock price target is $0.25, which is an increase of 78.57% from the latest price.

Price Target

$0.25

(78.57% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error